PANEL DISCUSSION: Lessons Learned from Failed and Discontinued Clinical Trials for the Treatment of Glioblastoma
Time: 5:15 pm
day: Day Two
- Debate the common challenges with moving GBM clinical trials forward
- What can we learn from the plethora of failed phase 2 trials?
- With a high failure rate of phase 3 glioblastoma trials, panellists examine the need for greater reliability
of earlier studies